Am J Sports Med 41(4):795803 Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M (2010) Use of platelet-rich plasma for the treatment of refractory jumpers knee
Animal toxicology studies spanning three decades have found no evidence of mutagenic, genotoxic, or carcinogenic effects
Mechanisms : Reduces TNF-alpha (key inflammatory marker) Lowers IL-6 and IL-1 (inflammatory cytokines) Modulates immune cell activity Protects tissues from inflammatory damage Applications : Joint pain (arthritis, synovitis) Inflammatory bowel conditions Autoimmune conditions (supportive therapy) General systemic inflammation Protocol : 1-2mg daily injectable, 8-12 weeks Expected results : 40-60% inflammation reduction, improved symptoms, better quality of life
As for peptides, they are generally well-tolerated, but its always best to do a patch test before using them all over your face